Cogent Biosciences Stock 346% Surge Fueled by New Stake
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
A straightforward rationale for incorporating Equal Weighted Indices into a portfolio, emphasizing diversification and simplicity.
22,501 articlesA Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
The first 30 days after a lease is signed can determine loyalty and loan risk. This report shows how hidden costs dur...
When a fintech stalwart like Fiserv experiences a pullback, it can ripple through the broader market. This guide expl...
A look at WWII-era weapons that helped allies reveals how innovation and mass production built a durable defense base...
Stocks with elevated short interest are driving today’s moves as investors weigh earnings signals and macro risks. Th...
A new state-grade iOS exploit kit is slipping past Apple defenses to drain crypto wallets on iPhone. Researchers warn...
The U.S. and Gulf states have pressed Kyiv for access to Ukraine’s interceptor tech as Western stocks of high-cost mi...
When mining stocks fall, investors want to know the why and what next. This guide breaks down the drivers behind hecl...
A growing number of couples are missing coordinated claiming strategies, shaving hundreds of dollars from lifetime So...
Curious about the 2027 Social Security COLA? This guide breakers down how the cola is set, what history suggests, and...
A single viral moment can grab attention, but your hardest-hitting finance lessons come from everyday decisions. Lear...
AppLovin posted stronger-than-expected Q4 results with robust margins and a strategic pivot to e-commerce ads, while ...